Entries by Viola Appiah Danquah

HVTN 807

This study is assessing an experimental vaccine called 426c.Mod.Core-C4b adjuvanted with 3M-052-AF + Alum immunization in combination with an antiretroviral analytical treatment interruption (ATI) in people living with HIV between the ages of 18 to 55. This study is currently enrolling participants.

HVTN 307

This study is assessing the safety and immunogenicity of ferritin nanoparticles expressing native-like HIV-1 envelope trimers followed by an mRNA boost in adults without HIV between the ages of 18 to 55 . This study is currently enrolling participants.

HVTN 142

This study is assessing the Safety, Reactogenicity and Immunogenicity of VIR-1388 (an HIV vaccine candidate) compared with Placebo in Healthy Participants without HIV between the ages of 18 to 55. This study is currently enrolling participants.